ADVOCATE. CONNECT. INNOVATE.

Member Resources

Research & DocumentationBack

Elsevier

Contact:
Peg Renery
P.Renery@Elsevier.com
650-892-2342

ELS Portfolio Value ChainSpecial packages of Elsevier Life Science Solutions are available to members of CLSA to help accelerate drug discovery and development. Elsevier Life Science Solutions is a portfolio of information solutions that work together intelligently, supporting R&D work in the discovery, pre-clinical, clinical and post-launch phases. This portfolio aims to help researchers achieve better outcomes.

  • Improve target and lead candidate identification thanks to linked biological, pharmacological and chemical data.
  • Reduce the time and cost of drug discovery — validate and prioritize innovative targets and leads early, ensuring effective ‘Go/No-go’ decisions.
  • Get robust support for pharmacovigilance and other regulatory and medical affairs functions.

Member Benefits

Tailored to smaller enterprises, the packages are flexible and offer access to a range of scientific information solutions that provide critical insights and drive actionable outcomes.

Life Science –

Biology Research Package

Life Science – Chemistry Research Package Medical Device –

Diagnostic Equipment Research Package

Lab Services – Research Package
ScienceDirect

Corporate Edition CompleteScienceDirect

Cell Press Collection

Embase

Reaxys

ScienceDirect

Corporate Edition

Complete

Scopus

Scopus

ScienceDirect

Corporate Edition

Complete

Embase

Scopus

ScienceDirect

Corporate Edition Complete

More Information
To learn more about these packages and pricing, please contact Elsevier Account Executive Peg Renery by phone 650-892-2342 or email: P.Renery@Elsevier.com. Be sure to identify yourself as a CLSA Member. Additional information about Elsevier Life Science Solutions is available here.